Fieldpoint Private Securities’s Bio-Techne TECH Stock Holding History

Fieldpoint Private Securities’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$16K	Sell	180 -300	-63%	-$28.1K	﹤0.01%	647
2022 Q1	$52K	Buy	480 +60	+14%	+$6.19K	0.01%	586
2021 Q4	$54K	Hold	420	–	–	0.01%	592
2021 Q3	$51K	Buy	420 +20	+5%	+$2.43K	0.01%	577
2021 Q2	$46K	Hold	400	–	–	0.01%	602
2021 Q1	$38K	Hold	400	–	–	0.01%	631
2020 Q4	$32K	Buy	+400	New	+$29K	0.01%	570

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Fieldpoint Private Securities's TECH Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Bio-Techne (TECH) stake by 63% in Q2 2022, selling an estimated $28.1K and leaving 180 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Fieldpoint Private Securities first reported a position in TECH in Q4 2020 and has held it in 7 quarters since. The position peaked at $54K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Fieldpoint Private Securities held 180 shares of Bio-Techne worth $16K as of Q2 2022.
Fieldpoint Private Securities sold 300 Bio-Techne shares in Q2 2022, an estimated $28.1K.
Bio-Techne made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #647 holding.
Fieldpoint Private Securities first reported a position in Bio-Techne in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's Bio-Techne position peaked at $54K in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.